Do we really need a better way to give heparin in acute cerebral ischemia?

Stroke

Volumn 33, Issue 3, 2002, Pages 659-660

  Hart, Robert G ^a,c   Easton, J Donald ^b  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cerebral ischemia; Heparin; Stroke, acute

Indexed keywords

HEPARIN;

ANTICOAGULANT THERAPY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK;

EID: 0036200275     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/str.33.3.659     Document Type: Editorial

References (9)

1. Development of practice guidelines
2. Anticoagulants for acute ischemic stroke (Cochrane Review)
3. Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke
4. Cerebral venous thrombosis and thrombolysis
5. European Stroke Initiative recommendations for stroke management
6. Low molecular-weight heparin vs. aspirin in patients with acute ischemic stroke and atrial fibrillation: A double blind randomized trial
7. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial
8. The International Stroke Trial (IST): A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischemic stroke
9. Short-term prognosis after emergency department diagnosis of TIA